PCSK9 INHIBITOR EVOLOCUMAB REDUCES CARDIOTOXICITYAND INFLAMMATION INDUCED BY DOXORUBICIN-HER2 BLOCKING AGENT SEQUENTIAL TREATMENT THROUGH MYD88/NF-KB/MTORC1 PATHWAYS
EUROPEAN HEART JOURNAL SUPPLEMENTS（2021）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined